Quiz: Medicines: History, Regulation, Discovery — 9 domande

1. What is the primary focus of pharmacology as a scientific discipline?

A. The study of the economic impact of medicines

B. The study of drug discovery, effects, and use

C. The legal regulation of medicines

D. The manufacturing process of pharmaceuticals

Answer: (B)

Spiegazione

Pharmacology is the scientific study of drugs, including their discovery, effects, mechanisms of action, and therapeutic uses. It encompasses understanding how drugs interact with biological systems to produce effects.

2. What is the primary purpose of a pharmacopée?

A. To serve as an official reference book defining standards for raw materials

B. To list all available medicines in a country

C. To regulate the price of medicines

D. To describe the manufacturing process of drugs

Answer: (A)

Spiegazione

The pharmacopée acts as an official reference with standards for drug purity and quality, ensuring consistency and safety.

3. Which historical milestone marked the first systematic documentation of remedies and medicinal substances?

A. The development of the ATC classification system

B. The invention of the microscope in the 17th century

C. The Egyptian papyrus dating from 1550 BC

D. The discovery of penicillin by Fleming

Answer: (C)

Spiegazione

The Egyptian papyrus from 1550 BC is one of the earliest known systematic pharmacopoeias, documenting remedies and medicinal substances, marking a significant milestone in the history of medicines.

4. Which regulatory body in France is responsible for drug approval?

A. ANSM

B. EMA

C. FDA

D. LFB

Answer: (A)

Spiegazione

ANSM (Agence Nationale de Sécurité du Médicament) is the French authority responsible for drug approval, while EMA oversees Europe-wide regulation.

5. What is the main purpose of the European Medicines Agency (EMA) in the regulation of medicines?

A. To sell medicines directly to consumers

B. To evaluate, supervise, and approve medicines for safety, efficacy, and quality across Europe

C. To conduct clinical trials for new drugs

D. To manufacture medicines for the European market

Answer: (B)

Spiegazione

The EMA is responsible for the scientific evaluation, supervision, and approval of medicines in the European Union, ensuring they meet safety, efficacy, and quality standards before they are marketed.

6. Which phase of drug development primarily assesses efficacy?

A. Clinical

B. Preclinical

C. Post-marketing surveillance

D. Manufacturing

Answer: (A)

Spiegazione

Clinical trials (phases I-IV) are designed to assess the safety and efficacy of a drug in humans.

7. What is an example of a biotechnological drug source?

A. Monoclonal antibodies

B. Willow bark

C. Arsenic compounds

D. Aspirin

Answer: (A)

Spiegazione

Monoclonal antibodies are developed through biotechnological methods, unlike natural or synthetic chemical sources.

8. Which of the following is NOT a route of administration for medicines?

A. Intradermal

B. Intravenous

C. Inhalatory

D. Subcutaneous

Answer: (C)

Spiegazione

Inhalatory is a common route (via inhalation), whereas intradermal (within the skin) is less common but still valid; however, 'Inhalatory' is more precise as a route of administration.

9. Which historical figure is associated with early contributions to medicine and observation in Greece?

A. Hippocrates

B. Galileo Galilei

C. Louis Pasteur

D. Alexander Fleming

Answer: (A)

Spiegazione

Hippocrates is known as the 'Father of Medicine' for his foundational contributions in Greece, while other figures contributed in different eras and contexts.